Increased islet apoptosis in Pdx1+/- mice

被引:301
作者
Johnson, JD
Ahmed, NT
Luciani, DS
Han, ZQ
Tran, H
Fujita, J
Misler, S
Edlund, H
Polonsky, KS
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Barnes Jewis Hosp,Renal Div, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Internal Med, Barnes Jewis Hosp,Metab Div, St Louis, MO 63110 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Umea Univ, Umea Ctr Mol Med, Umea, Sweden
关键词
D O I
10.1172/JCI200316537
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mice with 50% Pdx1, a homeobox gene critical for pancreatic development, had worsening glucose tolerance with age and reduced insulin release in response to glucose, KCl, and arginine from the perfused pancreas. Surprisingly, insulin secretion in perifusion or static incubation experiments in response to glucose and other secretagogues was similar in islets isolated from Pdx1(+/-) mice compared with Pdx1(+/+) littermate controls. Glucose sensing and islet Ca2+ responses were also normal. Depolarization-evoked exocytosis and Ca2+ currents in single Pdx1(+/-) cells were not different from controls, arguing against a ubiquitous beta cell stimulus-secretion coupling defect. However, isolated Pdx1(+/-) islets and dispersed beta cells were significantly more susceptible to apoptosis at basal glucose concentrations than Pdx1(+/+) islets. Bcl(XL) and Bcl-2 expression were reduced in Pdx1(+/-) islets. In vivo, increased apoptosis was associated with abnormal islet architecture, positive TUNEL, active caspase-3, and lymphocyte infiltration. Although similar in young mice, both beta cell mass and islet number failed to increase with age and were approximately 50% less than controls by one year. These results suggest that an increase in apoptosis, with abnormal regulation of islet number and beta cell mass, represents a key mechanism whereby partial PDX1 deficiency leads to an organ-level defect in insulin secretion and diabetes.
引用
收藏
页码:1147 / 1160
页数:14
相关论文
共 66 条
  • [1] β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes
    Ahlgren, U
    Jonsson, J
    Jonsson, L
    Simu, K
    Edlund, H
    [J]. GENES & DEVELOPMENT, 1998, 12 (12) : 1763 - 1768
  • [2] An optimized approach to membrane capacitance estimation using dual-frequency excitation
    Barnett, DW
    Misler, S
    [J]. BIOPHYSICAL JOURNAL, 1997, 72 (04) : 1641 - 1658
  • [3] Sustained proliferation of PDX-1+ cells derived from human islets
    Beattie, GM
    Itkin-Ansari, P
    Cirulli, V
    Leibowitz, G
    Lopez, AD
    Bossie, S
    Mally, MI
    Levine, F
    Hayek, A
    [J]. DIABETES, 1999, 48 (05) : 1013 - 1019
  • [4] Calcium - a life and death signal
    Berridge, MJ
    Bootman, MD
    Lipp, P
    [J]. NATURE, 1998, 395 (6703) : 645 - 648
  • [5] Perspective:: Postnatal pancreatic β cell growth
    Bonner-Weir, S
    [J]. ENDOCRINOLOGY, 2000, 141 (06) : 1926 - 1929
  • [6] Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion
    Brissova, M
    Shiota, M
    Nicholson, WE
    Gannon, M
    Knobel, SM
    Piston, DW
    Wright, CVE
    Powers, AC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) : 11225 - 11232
  • [7] Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1.: Importance of chromatin structure in directing promoter binding.
    Chakrabarti, SK
    James, JC
    Mirmira, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) : 13286 - 13293
  • [8] Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation
    Cnop, M
    Hannaert, JC
    Hoorens, A
    Eizirik, DL
    Pipeleers, DG
    [J]. DIABETES, 2001, 50 (08) : 1771 - 1777
  • [9] DEAR TN, 1995, DEVELOPMENT, V121, P2909
  • [10] Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes
    Donath, MY
    Gross, DJ
    Cerasi, E
    Kaiser, N
    [J]. DIABETES, 1999, 48 (04) : 738 - 744